ArticleFrontiers in immunology2025
Value of dynamic changes in inflammatory biomarkers for predicting intravenous immunoglobulin resistance in children with Kawasaki disease.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study assessed the predictive value of dynamic laboratory parameter changes before and after intravenous immunoglobulin (IVIG) treatment for IVIG resistance in children with Kawasaki disease (KD). Methods: Children with KD were stratified based on the occurrence of IVIG resistance. Logistic regression analyses were conducted to identify independent risk factors. The predictive performance of variables and their fractional changes (FC) was evaluated through receiver operating characteristic (ROC) curve analysis. Nonlinear associations between predictors and outcomes were examined via restricted cubic spline (RCS) analysis. Results: The Soochow cohort analyzed 1,796 children, with IVIG resistance observed in 140 cases (7.8%). 636 children from the Anhui cohort were included in external validation. Multivariate regression analysis identified pre-treatment CLR and Hb, post-treatment CLR, LMR, NLR, Hb, and FCs in WBC, Hb, NE%, and NE count as significant independent predictors of IVIG resistance (P < 0.05). ROC analysis demonstrated that WBC(FC) and NE count(FC) were the strongest predictors of IVIG resistance, with AUCs of 0.7677 and 0.7818, respectively, outperforming other parameters. The combined AUC of FC was 0.8307 in the Soochow cohort and 0.8564 in the validation cohort. RCS analysis revealed significant nonlinear relationships between predictors and IVIG resistance. Conclusion: Fractional changes in WBC and NE count were established as robust predictors of IVIG resistance in KD. Future efforts should focus on developing predictive models with thresholds and dynamic risk assessments at various time points to enhance the accuracy of IVIG resistance prediction. Clinicians should closely monitor children with IVIG resistance risk factors and reassess the risk after first treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.